US Patent No. 9,272,028


Patent No. 9,272,028
Issue Date March 01, 2016
Title Norovirus Vaccine Formulations
Inventorship Charles Richardson, Bozeman, MT (US)
Thomas S. Vedvick, Federal Way, WA (US)
Thomas R. Foubert, Bozeman, MT (US)
William T. Tino, Belgrade, MT (US)
Assignee TAKEDA VACCINES, INC., Bozeman, MT (US)

Claim of US Patent No. 9,272,028

1. A composition comprising a first monovalent virus like particle (VLP) derived from a genogroup I Norovirus and a second
monovalent VLP derived from a genogroup II Norovirus and at least one adjuvant, wherein the adjuvant is monophosphoryl lipid
A (MPL) and/or an aluminum salt, and wherein the composition is formulated as a liquid.